Want to see GB:KOO full AI Analyst Report?
Top Page
Kooth
(LSE:KOO)
Select Model
Select Model
Rating:70Outperform
Price Target:
215.00 p
▲(47.26% Upside)
Action:Reiterated
Date:08/29/26
The score is primarily supported by strong financial quality—especially the conservatively financed, near-zero-debt balance sheet and improved profitability. Technicals are constructive with price above major moving averages, but overbought RSI and a negative MACD introduce near-term caution. Valuation is the main drag due to the higher P/E and no provided dividend yield.
Positive Factors
Conservative Balance Sheet
Near-zero leverage materially limits financial risk and interest burden, while the larger equity base provides greater resilience to contract volatility and supports continued investment in the digital platform and clinical service capacity.
Negative Factors
Recent Revenue Contraction
The latest revenue decline suggests that demand, contract timing, renewals, or commissioned populations may be volatile. A prolonged slowdown would weaken operating leverage and make future growth more dependent on winning large public-sector contracts.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Near-zero leverage materially limits financial risk and interest burden, while the larger equity base provides greater resilience to contract volatility and supports continued investment in the digital platform and clinical service capacity.
Read all positive factors
Kooth (KOO) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£67.14M
Dividend YieldN/A
Average Volume (3M)118.32K
Price to Earnings (P/E)24.5
Beta (1Y)0.88
Revenue Growth-5.18%
EPS Growth-66.95%
CountryUK
Employees554
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.08
Shares Outstanding36,290,314
10 Day Avg. Volume270,426
30 Day Avg. Volume118,319
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.32
Price to Sales (P/S)0.66
P/FCF Ratio6.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£330.00Price Target Upside126.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.09
Revenue Forecast (FY)£63.13M
Kooth Business Overview & Revenue Model
Company Description
Kooth plc, together with its subsidiaries, provides digital mental health services to children, young people, and adults in the United Kingdom. It operates online platforms that offers various therapeutic support and interventions, including anony...
How the Company Makes Money
Kooth makes money primarily by contracting with public-sector bodies to provide access to its digital mental health platforms and associated clinical services. The company’s core revenue stream is service income from commissioned contracts—typical...
Kooth Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
88
Very Positive
Cash Flow
64
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 63.29M | 66.74M | 33.34M | 20.12M | 16.68M |
| Gross Profit | 40.09M | 51.99M | 25.86M | 13.86M | 11.59M |
| EBITDA | 10.23M | 14.53M | 1.51M | 1.32M | 1.65M |
| Net Income | 2.61M | 8.03M | -169.00K | -716.00K | -310.00K |
Balance Sheet | |||||
| Total Assets | 39.26M | 43.03M | 30.68M | 16.14M | 13.78M |
| Cash, Cash Equivalents and Short-Term Investments | 21.58M | 21.84M | 11.00M | 8.49M | 7.08M |
| Total Debt | 0.00 | 23.00K | 44.00K | 68.00K | 0.00 |
| Total Liabilities | 7.67M | 13.28M | 9.93M | 5.62M | 2.81M |
| Stockholders Equity | 31.59M | 29.75M | 20.76M | 10.52M | 10.97M |
Cash Flow | |||||
| Free Cash Flow | 6.20M | 17.67M | 1.58M | 1.33M | -744.00K |
| Operating Cash Flow | 6.27M | 17.79M | 1.87M | 4.38M | 1.85M |
| Investing Cash Flow | -4.45M | -6.30M | -8.71M | -3.05M | -2.60M |
| Financing Cash Flow | -1.48M | 0.00 | 9.39M | 81.00K | 0.00 |
Kooth Technical Analysis
Positive
146.00
Price Trends
157.88
Positive
153.90
Positive
136.06
Positive
Market Momentum
8.00
Negative
69.53
Neutral
68.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:KOO, the sentiment is Positive. The current price of 146 is below the 20-day moving average (MA) of 158.18, below the 50-day MA of 157.88, and above the 200-day MA of 136.06, indicating a bullish trend. The MACD of 8.00 indicates Negative momentum. The RSI at 69.53 is Neutral, neither overbought nor oversold. The STOCH value of 68.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:KOO.
Kooth Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £67.14M | 24.54 | 8.84% | ― | -5.18% | -66.95% | |
56 Neutral | £16.42M | -3.83 | -16.18% | ― | 13.04% | 15.88% | |
56 Neutral | £265.41M | 154.43 | 0.83% | ― | 14.84% | -15.14% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | £172.05K | -0.03 | -49.78% | ― | ― | ― | |
44 Neutral | £16.73M | -8.09 | -62.89% | ― | -9.11% | 18.91% |
* Healthcare Sector Average
GB:KOO
Kooth
185.00
33.00
21.71%
GB:COG
Cambridge Cognition Holdings
31.00
-3.00
-8.82%
GB:IXI
IXICO plc
7.50
-4.35
-36.71%
GB:TRLS
Trellus Health PLC
0.04
-0.46
-92.00%
GB:OPT
Optima Health PLC
244.00
24.13
10.97%
Kooth Corporate Events
Business Operations and StrategyRegulatory Filings and Compliance
Kooth Updates Voting Share Capital After Treasury Share Transfer
Neutral
Aug 12, 2026
Kooth plc, a specialist in digital mental and behavioural health services in the U.K. and U.S., operates clinically accredited platforms that offer self-guided tools, peer support, and professional therapy across large youth and general population...
Business Operations and StrategyRegulatory Filings and Compliance
Kooth updates share capital after treasury transfer and option exercise
Neutral
Aug 3, 2026
Kooth plc has transferred 9,395 ordinary shares from its treasury account to satisfy share options exercised by former employees under its Long Term Incentive Plan. Following this move, the company’s issued share capital stands at 36,694,683...
Business Operations and StrategyFinancial Disclosures
Kooth boosts EBITDA and cash as California and UK programmes gain traction
Positive
Jul 29, 2026
Kooth reported that revenue for the half year to 30 June 2026 is expected to be £30.8m, slightly down from £32.1m a year earlier due to planned tapering of California product development income and adverse foreign exchange effects. Adjus...
Business Operations and StrategyRegulatory Filings and Compliance
Kooth Updates Share Capital Following Treasury Transfer and Option Exercise
Neutral
Jun 26, 2026
Kooth plc has transferred 1,883 ordinary shares from its treasury to satisfy options exercised by a former employee under its Long Term Incentive Plan, slightly adjusting its capital structure. Following this transaction, the company’s issue...
Business Operations and StrategyShareholder Meetings
Kooth shareholders back growth strategy as all AGM resolutions pass
Positive
Jun 23, 2026
Kooth plc, a digital mental health specialist serving over 20 million users in the UK and US, leverages its Kooth, Qwell and Soluna platforms to provide accredited online therapeutic support, and is recognised as a leading provider for under-18s i...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.